BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 18404148)

  • 1. Detection, clinical relevance and specific biological properties of disseminating tumour cells.
    Pantel K; Brakenhoff RH; Brandt B
    Nat Rev Cancer; 2008 May; 8(5):329-40. PubMed ID: 18404148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New technologies for the detection of circulating tumour cells.
    Gerges N; Rak J; Jabado N
    Br Med Bull; 2010; 94():49-64. PubMed ID: 20418405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN.
    Wollenberg B; Walz A; Kolbow K; Pauli C; Chaubal S; Andratschke M
    Onkologie; 2004 Aug; 27(4):358-62. PubMed ID: 15347890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of micrometastases and circulating tumour cells using molecular biology technics in solid tumours].
    Schleiermacher G; Delattre O
    Bull Cancer; 2001 Jun; 88(6):561-70. PubMed ID: 11459702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
    Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
    J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K; Sollier C; Jabado N
    Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of isolated tumor cells and micrometastases in patients with gastric carcinoma].
    Kodera Y; Nakanishi H; Ito S; Nakao A
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):817-23. PubMed ID: 17565240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
    Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minimal residual disease in breast cancer: detection and clinical relevance].
    Pantel K; Wölfle U
    Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in colorectal cancer: detection methods and clinical significance.
    Tsouma A; Aggeli C; Pissimissis N; Lembessis P; Zografos GN; Koutsilieris M
    Anticancer Res; 2008; 28(6B):3945-60. PubMed ID: 19192655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.
    Klein CA
    Eur J Cancer; 2008 Dec; 44(18):2721-5. PubMed ID: 19022661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes.
    Kowalewska M; Chechlińska M; Markowicz S; Kober P; Nowak R
    Eur J Cancer; 2006 Nov; 42(16):2671-4. PubMed ID: 16978860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migrating and circulating breast carcinoma cells are within active phases of the cell cycle.
    Kubens BS; Feldner JC; Brandt B; Zänker KS
    Anticancer Res; 2002; 22(2A):899-903. PubMed ID: 12014669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular correlates of site-specific metastasis.
    Dai CY; Haqq CM; Puzas JE
    Semin Radiat Oncol; 2006 Apr; 16(2):102-10. PubMed ID: 16564445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating tumor cells: isolation, quantification, and relevance of their translation into clinical practice].
    Olivier Gómez C; Carballido Rodríguez J
    Actas Urol Esp; 2010 Jan; 34(1):3-5. PubMed ID: 20223125
    [No Abstract]   [Full Text] [Related]  

  • 20. The "microscopic" revolution in breast carcinoma.
    Cristofanilli M
    Cancer; 2005 Mar; 103(5):877-80. PubMed ID: 15611972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.